Hinova Pharmaceuticals Future Growth
Future criteria checks 0/6
Hinova Pharmaceuticals is forecast to grow earnings at 79.8% per annum. EPS is expected to grow by 79.9% per annum.
Key information
79.8%
Earnings growth rate
79.9%
EPS growth rate
Pharmaceuticals earnings growth | 18.3% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 14 Jun 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2024 | N/A | -266 | -357 | -252 | N/A |
12/31/2023 | N/A | -294 | -355 | -256 | N/A |
9/30/2023 | 2 | -317 | -435 | -324 | N/A |
6/30/2023 | 2 | -319 | -399 | -295 | N/A |
3/31/2023 | 2 | -290 | -381 | -306 | N/A |
12/31/2022 | 2 | -302 | -384 | -315 | N/A |
9/30/2022 | N/A | -319 | -345 | -294 | N/A |
6/30/2022 | N/A | -306 | -334 | -295 | N/A |
3/31/2022 | N/A | -343 | -300 | -265 | N/A |
12/31/2021 | N/A | -306 | -248 | -228 | N/A |
12/31/2020 | N/A | -490 | -246 | -244 | N/A |
12/31/2019 | 4 | -112 | -83 | -81 | N/A |
12/31/2018 | 4 | -39 | -19 | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688302 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 688302 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 688302 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if 688302's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 688302's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 688302's Return on Equity is forecast to be high in 3 years time